Acute Graft-Versus-Host Disease Biomarkers Measured During Therapy Can Predict Treatment Outcomes: A Blood and Marrow Transplant Clinical Trials Network Study. Blood, 119, 3854-3860. presented at the 04/2012.. (2012).
GVHD Biomarkers Measured During Treatment Independently Predict Response to Therapy and Survival: A Blood and Marrow Transplant Clinical Trials Network Study (Abstract). In . presented at the 2011, Paris, France. Retrieved from http://www.congrex.ch/ebmt2011/. (2011).
Graft-versus-Host Disease Treatment: Predictors of Survival. Biol Blood Marrow Transplant, 16, 1693-1699. presented at the 12/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20541024. (2010).
Mycophenolate Pharmacokinetics and Association with Response to Acute Graft-Versus-Host Disease Treatment from the Blood and Marrow Transplant Clinical Trials Network. Biol Blood Marrow Transplant, 16, 421-429. presented at the 03/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19925875. (2010).
Etanercept, Mycophenolate, Denileukin, or Pentostatin Plus Corticosteroids for Acute Graft-Versus-Host Disease: A Randomized Phase 2 Trial from the Blood and Marrow Transplant Clinical Trials Network. Blood, 114, 511-517. presented at the 07/2009. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19443659. (2009).